UCSF-Mount Zion is a clinical research site located in San Francisco, California, United States 94115.
Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.
UCSF-Mount Zion has participated in 10 clinical trials with 2 currently active.
Therapeutic areas: Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Bladder Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter.
Sponsors: National Cancer Institute (NCI), AIDS Malignancy Consortium, ECOG-ACRIN Cancer Research Group.
Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
UCSF-Mount Zion has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UCSF-Mount Zion has 10 clinical trials on record, with 2 currently active. Their work covers Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Bladder Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter.
Yes — UCSF-Mount Zion holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.